Zealand Pharma A/S (CPH: ZEAL)
Denmark
· Delayed Price · Currency is DKK
728.00
-28.50 (-3.77%)
Dec 20, 2024, 4:59 PM CET
Zealand Pharma Employees
Zealand Pharma had 253 employees as of December 31, 2023. The number of employees increased by 57 or 29.08% compared to the previous year.
Employees
253
Change (1Y)
57
Growth (1Y)
29.08%
Revenue / Employee
257.95K DKK
Profits / Employee
-3.53M DKK
Market Cap
51.43B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Novo Nordisk A/S | 64,319 |
Coloplast A/S | 16,639 |
Genmab A/S | 2,204 |
Demant A/S | 21,623 |
H. Lundbeck A/S | 5,681 |
H. Lundbeck A/S | 5,681 |
ALK-Abelló A/S | 2,824 |
Ambu A/S | 5,196 |
Zealand Pharma News
- 2 days ago - Zealand Pharma CEO says Novo's CagriSema data supports monotherapy approach to cagrilintide - Reuters
- 2 days ago - FDA drug rejection hits Zealand Pharma shares - Financial Times
- 2 days ago - FDA rejects Zealand Pharma's drug for short bowel syndrome - Seeking Alpha
- 2 days ago - US FDA declines to approve Zealand Pharma's bowel disease drug - Reuters
- 2 days ago - U.S. Food and Drug Administration issues Complete Response Letter for the glepaglutide New Drug Application for the treatment of short bowel syndrome - GlobeNewsWire
- 3 days ago - Zealand Pharma And Eli Lilly: Strategic Focus On Weight Management And Future Outlook - Seeking Alpha
- 6 days ago - Zealand Pharma A/S 2024 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 12 days ago - Zealand Pharma starts Phase 2b trial for obesity drug candidate petrelintide - Reuters